Abstract. Polycystic ovarian syndrome (PCOS) is characterized by chronic anovulation, hyperandrogenism and polycystic ovaries. To date, the molecular mechanisms underlying PCOS have remained to be fully elucidated. As recent studies have revealed a positive association between mitochondrial dysfunction and PCOS, current investigations focus on mutations in the mitochondrial genome of patients with POCS. The present study reported a Chinese patient with PCOS. Sequence analysis of the mitochondrial genome showed the presence of homoplasmic ND5 T12338C and tRNA Ser (UCN) C7492T mutations as well as a set of polymorphisms belonging to the human mitochondrial haplogroup F2. The T12338C mutation is known to decrease the ND5 mRNA levels and to inhibit the processing of RNA precursors. The C7492T mutation, which occurred at the highly conserved nucleotide in the anticodon stem of the tRNA Ser (UCN) gene, is important for the tRNA steady-state level as well as the aminoacylation ability. Therefore, the combination of the ND5 T12338C and tRNA Ser (UCN) C7492T mutations may lead to mitochondrial dysfunction, and is likely to be involved in the pathogenesis of PCOS. The present study provided novel insight into the molecular mechanisms of PCOS.
Introduction
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in reproductive-age women, affecting 8-18% (1) . Insulin resistance (IR) is considered to be the main pathological factor responsible for the hormonal disturbances associated with the syndrome (2), and IR in PCOS patients confers a substantial risk for developing type 2 diabetes and cardiovascular diseases (3, 4) . Furthermore, IR has been reported to be linked with reduced mitochondrial respiration (5) . Reduced expression of nuclear-encoded genes involved in oxidative phosphorylation (OXPHOS) has been reported in skeletal muscle of patients with PCOS (6) . In addition, analysis of oxygen consumption in blood mononuclear cells (leukocytes) indicated that in women with PCOS, mitochondrial complex I respiration is reduced compared with that in age-and body mass index-matched control subjects (7) . Due to this central role of mitochondrial impairment in PCOS, current studies focus on mutations in the mitochondrial genome of patients with POCS.
With the purpose of elucidating the molecular basis of PCOS, the present study performed a systematic and extensive mutational screening for pathogenic mutations in the mitochondrial genome of a patient with PCOS. Previous studies by our group showed that mitochondrial OXPHOS complexes are hot spots for mutations associated with PCOS, as well as several mitochondrial transfer (mt-t)RNA mutations (8, 9) . These tRNA mutations included tRNA Gln T4395C,  tRNA  Cys G5821A, tRNA  Asp A7543G, tRNA  Lys A8343G,  tRNA Arg T10454C and tRNA Glu A14693G. These mt-tRNA mutations were localized at highly conserved nucleotides, which caused structural and functional alternations, and consequently resulted a failure of mt-tRNA metabolism. The present study reported on the clinical and molecular characterization of a Han Chinese patient with PCOS-IR. A sequence analysis of the mitochondrial genome showed the presence of ND5 T12338C and tRNA Ser (UCN) C7492T mutations. Laboratory assessment. Serum levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, progesterone, total testosterone (TT) and fasting insulin levels were measured by electrochemiluminescence immunoassays (Roche Diagnostics, Basel, Switzerland). The plasma glucose levels were measured using a Beckman glucose analyzer (Ramcon, Fullerton, CA, USA). Furthermore, an oral glucose tolerance test was performed. In brief, a blood sample was obtained from the antecubital vein at 0 and 120 min for measurement of plasma glucose concentrations, with 0 min denoting the level of fasting plasma glucose.
Subject and methods

Case
Patients with a plasma glucose concentration of <7.8 mmol/l at the 120-min time point were categorized as having normal glucose tolerance, while those with plasma glucose levels of 7.8-11.1 mmol/l were classified as having impaired glucose tolerance, and those with glucose levels of >11.1 mmol/l were indicated to have diabetes mellitus. The main outcome measure of IR was calculated using the homeostatic model assessment of IR (HOMA-IR), where a value of >3.16 denotes IR according to the following formula:
Molecular and genetic analysis. Total DNA was isolated from peripheral blood leukocytes of the patient using an Universal Genomic DNA Extraction kit version 3.0 (Takara Bio Inc., Otsu, Japan). The entire mtDNA was amplified in 24 overlapping fragments as previously described (11) 
Results and Discussion
Laboratory examination of the patient showed that the levels of TT were 2.89 nmol/l, and the LH/FSH ratio was 2.81. In addition, the patient was insulin resistant. The clinical laboratory parameters of the PCOS patient are listed in Table I . Mutational screening of the mitochondrial genome showed the presence of the homoplasmic ND5 T12338C and tRNA Ser (UCN) C7492T mutations ( Fig. 1) , belonging to the human mitochondrial haplogroup F2 (13) . Notably, the homoplasmic ND5 T12338C mutation was only detected in the patient with PCOS but not in the healthy controls. This mutation is a result of a replacement of the first amino acid, a translation-initiating methionine, with a threonine in the ND5 polypeptide (Fig. 2) . The encoding sequence of the first methionine in the ND5 gene is extraordinarily conserved among species and organelles ranging from bacteria to human mitochondria (14) . As a result, the truncated ND5 protein was expected to be shortened by two amino acids, since the ND5 T12338C mutation replaced the first amino acid from methionine to threonine and, as methionine is the translational initiation code, the mutant ND5 translates from the third methionine. As reported by a previous study, the ND5 T12338C mutation was also located in two nucleotides adjacent to the 3' end of the tRNA Leu (CUN) gene (15) . Consequently, this mutation altered respiratory function, as well as the processing of RNA precursors, thereby leading to a reduction in tRNA Leu (CUN) levels. The functional significance of the ND5 T12338C mutation in terms of mitochondrial physiology was further supported by studies reporting that the T12338C mutation may modulate the phenotypic expression of the deafness-associated 12S rRNA A1555G mutation, and that it was associated with essential hypertension and Leber's hereditary optic neuropathy (16, 17) . The homoplasmic ND1 T3308C mutation has been suggested to contribute to the higher penetrance of hearing loss in a large African pedigree compared with that in Japanese and French pedigrees carrying the tRNA Ser (UCN) T7511C mutation (18, 19) . A significant reduction in steady-state levels of ND1 mRNA and the adjacent tRNA Leu (UUR) observed in cybrids carrying the T3308C mutation was likely due to an alteration in the processing of the H-strand polycistronic RNA precursors or the destabilization of ND1 mRNA (20) . Thus, the ND5 T12338C mutation, which is similar to the ND1 T3308C mutation (14, 19) , may induce a reduction in ND5 mRNA expression levels, as well as the steady state level of tRNA Leu (CUN) ; therefore, this mutation may cause mitochondrial dysfunction and, since mitochondrial dysfunction is associated with the pathogenesis of PCOS-IR (6,7), we propose the ND5 T12338C mutation is associated with PCOS-IR.
The homoplasmic C7492T mutation occurred at position 26 in the anticodon stem of the tRNA Ser (UCN) -encoding gene (Fig. 3) . Mutation at this position is highly conserved among various species, which suggests that it may be associated with the pathogenesis of PCOS-IR (Fig. 4) . In addition, the C7492T mutation led to an alteration of base pairing (A26-U44), and identical base pairing at the same position in tRNA
Ile generated by the heteroplasmic T4295C mutation has been associated with altered tRNA metabolism in chronic progressive external ophthalmoplegia (21) . Therefore, it can be anticipated that the C7492T mutation may alter the tertiary structure of tRNA Ser (UCN) and, since the anticodon stem is critical for codon and anticodon interaction, this mutation may reduce the steady state level of tRNA Ser (UCN) as well as the aminoacylation ability. The resultant shortage of tRNA Ser (UCN) may be responsible for defects in mitochondrial protein synthesis. Consequently, the deficiency in respiratory chain function will cause a reduction in ATP synthesis and increase the generation of reactive oxygen species. Therefore, this mutation may have an active role in the pathogenesis of PCOS-IR. However, due to the complex molecular mechanisms of PCOS, it is likely that the C7492T and T12338C mutations alone are insufficient to produce the clinical phenotype; other factors, including nuclear genes, epigenetic modifications and environmental factors may contribute to the pathogenesis of PCOS.
